PLOSopen access
Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance
gene expression, cancer immunotherapy, immune response, cancer immunotherapy, cancer immunotherapy, immune response
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 269668
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.